The novel therapy of this peptide represents a exciting breakthrough in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide094734.bloguerosa.com/40642539/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment